| Korean guidelines for diagnosis and management of interstitial lung diseases: Hypersensitivity pneumonitis |
|
Byoung Soo Kwon1, Sooim Sin2, Kyung Hoon Kim3, Jinkyeong Park4, Beomsu Shin5, Hongseok Yoo6, Yong Hyun Kim7 |
1Division of pulmonary and critical care medicine, Seoul National University Bundang Hospital, Korea
2Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, National Medical Center, Seoul, Republic of Korea
3Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Incheon St. Mary's Hospital, The Catholic University of Korea, College of Medicine, Republic of Korea
4Department of Pulmonary, Allergy and Critical Care Medicine, Kyung Hee University College of Medicine, Kyung Hee University Hospital at Gangdong, Seoul, Republic of Korea
5Department of Allergy, Pulmonology and Critical Care Medicine, Gachon University Gil Medical Center, Gachon University College of Medicine, Incheon, Republic of Korea
6Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
7Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Bucheon St. Mary's Hospital, The Catholic University of Korea, College of Medicine, Republic of Korea |
Correspondence:
Yong Hyun Kim,
Email: kyh30med@catholic.ac.kr
|
Received: 12 December 2024 • Revised: 12 February 2025 • Accepted: 24 February 2025
*Byoung Soo Kwon and Sooim Sin contributed equally to this study as co-first authors. |
| Abstract |
|
Hypersensitivity pneumonitis (HP) is an immune-mediated interstitial lung disease characterized by heterogeneous clinical manifestations and complex diagnostic challenges. This clinical guideline aims to provide a comprehensive framework for the diagnosis and management of HP, with an emphasis on the evolving classification into fibrotic and non-fibrotic subtypes. Integrating current clinical guidelines and expert consensus, it addresses key aspects such as radiologic and histopathologic findings, diagnostic strategies, and pharmacologic management. Tailored to the healthcare context in Korea, this guideline offers clinicians a structured approach to diagnosing and managing HP, taking into account regional variations in antigen exposure and clinical presentation. The recommendations herein are based on both international and local data, aiming to improve outcomes for Korean patients through timely and accurate diagnosis, individualized treatment plans, and careful monitoring. |
|
PDF Links
Full text via DOI
Download Citation
